Portal vein thrombosis in a patient with HIV treated with a protease inhibitor-containing regimen

Acta Clin Belg. 2006 Jan-Feb;61(1):24-9. doi: 10.1179/acb.2006.005.

Abstract

We report a case of an HIV seropositive female patient treated with a protease inhibitor-containing regimen who developed recurrent severe life-threathening episodes of haematemesis over time, caused by ruptured oesophageal varices as a consequence of a portal vein thrombosis. Coagulation tests revealed a protein S deficiency, an elevated homocysteinemia and a constitutional elevated plasma factor VIII coagulant activity. These coagulopathies and the HIV infection are independent risk factors for developing venous thromboembolic events. The protease inhibitor treatment may have played a role in increasing the thromboembolic risk. The recurrent bleedings only stopped after invasive surgery. The invasive splenorenal shunt operation was in this case a life-saving procedure.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Antiretroviral Therapy, Highly Active / methods
  • Esophageal and Gastric Varices / diagnosis
  • Esophageal and Gastric Varices / etiology
  • Female
  • Follow-Up Studies
  • HIV Infections / complications
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV Seropositivity
  • Hematemesis / diagnosis
  • Hematemesis / etiology
  • Humans
  • Portal Vein*
  • Portography / methods
  • Protease Inhibitors / adverse effects*
  • Protease Inhibitors / therapeutic use
  • Recurrence
  • Risk Assessment
  • Severity of Illness Index
  • Venous Thrombosis / etiology*
  • Venous Thrombosis / physiopathology
  • Venous Thrombosis / surgery

Substances

  • Protease Inhibitors